PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas.
about
Effect of Fu-Zheng-Xiao-Liu Granules on Expression of Human Epidermal Growth Factor Receptor 2 (HER-2) and Proliferation and Apoptosis of Breast Cancer Cell Line SKBR-3.Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cellsPhosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.Superior in vitro and in vivo activity of trastuzumab-emtansine (T-DM1) in comparison to trastuzumab, pertuzumab and their combination in epithelial ovarian carcinoma with high HER2/neu expression.Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer.Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials.The impact of PI3K inhibitors on breast cancer cell and its tumor microenvironment.Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late
P2860
Q37551185-35B970FC-ABA4-4886-BA0C-9D9CB36AC2A0Q37644791-A8D54C3B-E8C1-4380-8171-080E5DD8BFC4Q37696147-3A023B78-4344-4A4F-8403-69EA24B2A058Q38680412-2FC0E721-5D98-4524-830B-108A982EA74BQ38752466-A8C2B99A-161A-4CA5-BCCB-DCA531060209Q45848384-9B0ED9FF-CCD8-4502-B99C-890BF6E48741Q55435506-377AE5DE-F88B-4565-8A12-67D4C0AA496AQ57169683-F354B742-D221-41D7-830F-993658B8E3BC
P2860
PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
PIK3CA oncogenic mutations rep ...... ing uterine serous carcinomas.
@ast
PIK3CA oncogenic mutations rep ...... ing uterine serous carcinomas.
@en
type
label
PIK3CA oncogenic mutations rep ...... ing uterine serous carcinomas.
@ast
PIK3CA oncogenic mutations rep ...... ing uterine serous carcinomas.
@en
prefLabel
PIK3CA oncogenic mutations rep ...... ing uterine serous carcinomas.
@ast
PIK3CA oncogenic mutations rep ...... ing uterine serous carcinomas.
@en
P2093
P2860
P4510
P356
P1476
PIK3CA oncogenic mutations rep ...... ing uterine serous carcinomas.
@en
P2093
Alessandro D Santin
Carlton L Schwab
Dan-Arin Silasi
Diana P English
Elena Ratner
Emiliano Cocco
Federica Predolini
Francesca Ferrari
Gary Altwerger
Jonathan D Black
P2860
P2888
P304
P356
10.1038/BJC.2015.306
P407
P577
2015-09-01T00:00:00Z
P5875
P6179
1007306347